Executive Search Success Story: Scaling Commercial & Regulatory Leadership at an IVD Manufacturer

How JRG Partners executed a highly confidential, multi-role North American retained search strategy that equipped a rapidly growing in-vitro diagnostics (IVD) manufacturer with the critical commercial, regulatory, quality, and manufacturing operations leadership required to scale molecular and companion diagnostics, accelerate assay commercialization, and expand international market share.

The Challenge

A rapidly growing in-vitro diagnostics manufacturer was experiencing a significant surge in demand across its molecular and companion diagnostics platforms, driven by widespread adoption throughout clinical networks and large health systems. To successfully commercialize its expanding test menu, scale complex instrument manufacturing, and maintain rigorous international regulatory compliance, the enterprise required a coordinated upgrade of its leadership ranks. Executive management identified several critical operational and commercial pressures:

• Fierce market competition from established diagnostics giants and agile clinical technology startups
• Increasingly complex global regulatory frameworks and shifting certification protocols for diagnostic assays
• Severe executive bandwidth constraints across product development and commercial scaling teams
• Acute technical scaling hurdles associated with transitioning from low-volume R&D to high-capacity instrument manufacturing
• Pronounced product commercialization, market penetration, and healthcare system adoption risks
• Substantial design-continuity and institutional knowledge-transfer risks within legacy product teams

The company’s board and CEO determined that mitigating these high-stakes developmental risks required a synchronized management structure spanning a Chief Operating Officer (COO), VP Regulatory Affairs, VP Quality Assurance, VP Manufacturing, VP Commercial Operations, Director of Molecular Diagnostics, and Director of Product Development. Successfully executing this comprehensive mandate required an executive search partner combining precise technical vertical literacy in diagnostics validation with an immediate connection to a nationwide network of passive life-sciences talent.

Why They Chose JRG Partners

Deep In-Vitro Diagnostics & Regulatory Specialization

Unlike generalist recruitment firms that lack immersion in specialized clinical validation methodologies, JRG Partners maintains dedicated executive search practices built explicitly around in-vitro diagnostics, molecular assay development, global regulatory quality architectures, and clinical commercial operations. Our consultants possess an intimate operational understanding of the strict clinical evaluation windows built into modern diagnostic product roadmaps.

Real Access to Passive Talent

The most effective commercialization leaders and quality directors within the diagnostics space are typically fully embedded in successful global product launches or driving active clinical platforms, meaning they rarely monitor public job boards. JRG Partners bypassed conventional recruitment channels entirely, leveraging long-standing sector relationships, life-sciences networks, and proprietary market intelligence to directly engage high-performing passive leaders invisible to standard sourcing methods.

Confidential Search Execution

Because this management build-out intersected directly with unreleased assay patents, sensitive clinical trial milestones, and upcoming health authority submissions, absolute discretion was a mandatory requirement. JRG Partners deployed a highly secure, confidential vetting framework that successfully protected the client’s competitive advantages, preserved team morale, and maintained total corporate confidence.

True North American Human Capital Reach

Sourcing specialized clinical and operational talent capable of guiding cross-border innovation required an outreach framework unconstrained by geography. JRG Partners deployed a coordinated strategy across primary medical-technology and biotech hubs throughout the United States and Canada, providing the client’s executive sponsors with a premium shorthand of proven, elite executives.

Our Executive Search Strategy

Phase 1 — Strategic Alignment & Competency Assessment

Our consultants partnered directly with the CEO, Board, and executive team to systematically map existing organizational gaps, identify hidden technical succession risks, clarify scaling milestones, and define the exact leadership competencies required for long-term growth. Rather than matching against legacy descriptions, we built forward-looking executive profiles dynamically tied to the company’s multi-year advanced test commercialization strategy.

Phase 2 — Multi-Sector Market Mapping

JRG Partners executed an exhaustive market-mapping initiative that targeted high-performing, process-driven environments across North America. Our comprehensive market map targeted key talent pools across global medical device manufacturers, specialized in-vitro diagnostics companies, biotechnology organizations, molecular laboratory systems, pharmaceutical businesses, precision engineering companies, and dedicated clinical research development organizations.

Phase 3 — Targeted Executive Engagement

Using a research-driven, discreet outreach framework, our consultants directly contacted and evaluated high-achieving executives with verified records of success in diagnostic product innovation, international commercial scaling, and global regulatory quality assurance. Only candidates demonstrating clear, measurable operational, quality, and commercialization impact advanced to the final evaluation round.

Phase 4 — Rigorous Assessment & Final Selection

Each finalist candidate underwent an extensive evaluation process looking far beyond basic professional credentials. Our consultants conversion-tested strategic and functional capabilities, regulated compliance framework agility, team-building and leadership philosophies, cross-functional communication skills, cultural alignment with rapid commercial scaling, and long-term retention potential.

Key Outcomes

• 500+ targeted diagnostics, medical device, and life-sciences manufacturing executive profiles systematically mapped across key North American commercial and technology corridors.
• Successfully placed and integrated a complete corporate leadership framework—spanning the COO, global regulatory vice presidents, and commercial operations directors—within a 12-month timeline.
• Unified separate cross-disciplinary development and commercial groups under a single, cohesive product launch strategy by installing proven healthcare transformation executives.
• Accelerated advanced molecular assay verification and platform integration by placing forward-thinking product development and clinical diagnostics directors.
• Mitigated instrument manufacturing scale-up risks and optimized supplier quality systems by placing specialized, data-driven manufacturing operations leaders.
• Protected proprietary intellectual property, upcoming product blueprints, and sensitive clinical study data during a high-stakes transition phase through strict search confidentiality.
• Provided the Board of Directors and CEO with a high-performance management framework explicitly equipped to eliminate long-term succession risks and drive profitable, compliant in-vitro diagnostics innovation at scale.